Bimamix, Oral Suspension for Calves
Introduction

Company name: Bimeda
Address: A division of Cross Vetpharm Group UK Limited
Bryn Cefni Industrial Park,
Llangefni,
Anglesey LL77 7XA.
Telephone: 0800 526769
Fax: 01248 725416
Email: sales@bimeda.co.uk
Presentation
Light pink coloured oral suspension containing 15% w/v sulfadiazine and 2.5 w/v neomycin sulphate.
Uses
For the treatment of diarrhoea in pre-ruminant calves associated with infections caused by organisms known to be, or suspected of being, susceptible to the combination of sufadiazine and neomycin.
Dosage and administration
4ml per 10 kg bodyweight twice daily for a maximum period of 5 days. This equates to 60 mg/kg sulfadiazine and 10 mg/kg neomycin twice daily.
Shake the bottle well before use. Administration is by oral drench.
Contra-indications, warnings, etc
Do not use in animals with known hypersensitivity to the active ingredient.
Do not exceed the recommended dosage or the period of treatment.
Do not use local anaesthetics of the procaine group during treatment as they are antagonistic to the sulphonamide component.
Do not use in calves with a functional rumen.
Do not use in lactating cows.
Do not use in foals and horses.
Special Warnings: Concurrent intravenous fluid therapy should be considered in dehydrated calves. Parenteral antibiotic treatment should be considered if a clinical response is not seen after 48 hours treatment.
Adverse reactions: Chronic use of oral neomycin may result in bacterial or fungal superinfections.
Withdrawal period: Animals intended for human consumption must not be slaughtered during treatment. Calves intended for human consumption may only be slaughtered after 28 days from the last treatment. Not intended for animals producing milk for human consumption.
Pharmaceutical precautions
Avoid contact with skin. Wash Hands after use.
Any unused product or waste materials should be disposed of in accordance with national requirements.
There is interaction and antagonism between sulphonamides and the vitamin B Complex. Do not use local anaesthetics of the procaine group during treatment, as they are antagonistic to the sulphonamide component.
Overdose: Good tolerance has been confirmed in calves at 3x and 5x times the recommended dose rate.
Legal category
POM-V
Packaging Quantities
250ml and 1 litre high density polyethylene bottles.
Further information
Nil
Marketing authorisation number
Vm 12597/4047.
Significant Changes